It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
This report aims to provide a comprehensive presentation of the global market for Healthcare Nanotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Nanotechnology. This report contains market size and forecasts of Healthcare Nanotechnology in global, including the following market information:
- Global Healthcare Nanotechnology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Healthcare Nanotechnology market was valued at US$ 211810 million in 2022 and is projected to reach US$ 391870 million by 2029, at a CAGR of 9.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry is crowded with producers and fierce competition. The U.S. has the highest share of income by region, at more than 48 percent.The key manufacturers are Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International etc. Top 3 companies occupied about 2% market share.
We surveyed the Healthcare Nanotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare Nanotechnology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Healthcare Nanotechnology Market Segment Percentages, by Type, 2022 (%)
- Nanomedicine
- Nano Medical Devices
- Nano Diagnosis
- Others
Global Healthcare Nanotechnology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Healthcare Nanotechnology Market Segment Percentages, by Application, 2022 (%)
- Anticancer
- CNS Product
- Anti-infective
- Others
Global Healthcare Nanotechnology Market, BRegion y and Country, 2018-2023, 2024-2029 ($ Millions)
Global Healthcare Nanotechnology Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Healthcare Nanotechnology revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Healthcare Nanotechnology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen
- Teva Pharmaceuticals
- Abbott
- UCB
- Roche
- Celgene
- Sanofi
- Merck & Co
- Biogen
- Stryker
- Gilead Sciences
- Pfizer
- 3M Company
- Johnson & Johnson
- Smith & Nephew
- Leadiant Biosciences
- Kyowa Hakko Kirin
- Shire
- Ipsen
- Endo International
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Healthcare Nanotechnology, market overview.
- Chapter 2: Global Healthcare Nanotechnology market size in revenue.
- Chapter 3: Detailed analysis of Healthcare Nanotechnology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Healthcare Nanotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
